International Stroke Conference 2025 – American Heart Association

Lys Therapeutics is proud to announce its participation in the International Stroke Conference 2025, organized by the American Heart Association. The event will take place in Los Angeles, California, USA, from February 5 to 7, 2025.

Dr. Manuel BLANC, our CEO and co-founder, will represent Lys Therapeutics at the conference, showcasing our commitment to advancing innovation in stroke care and neurovascular health.

#ISC25 #AHA #Stroke #Neurovascular #Innovation #Patients #Cytoprotection #BloodBrainBarrier #LysTherapeutics #LYS241